Epstein-Barr Virus Test

views updated

Epstein-Barr Virus Test


The Epstein-Barr virus test is a blood test, or group of tests, to determine the presence or absence of antibodies in the blood stream directed against proteins of the Epstein-Barr virus, the cause of infectious mononucleosis.


The test is primarily used to detect whether first time infection (called primary infection) with the Epstein-Barr virus is currently occurring, or has occurred within a short period of time. The pattern of the antibodies detected can, however, tell if the person has never been infected with the Epstein-Barr virus, or if the infection occurred in the more distant past. These tests are mostly utilized in the diagnosis of Epstein-Barr virus-associated infectious mononucleosis when the more common diagnostic test, the heterophile antibody, is negative, or in situations where the infection is manifesting unusual symptoms. Therefore, the tests are often not needed in a situation where a doctor believes that a person has mononucleosis and the heterophile test (also called the monospot test) is positive.

In addition, Epstein-Barr virus testing is usually not needed in the evaluation of a patient who has long-lasting fatigue, and may have the chronic fatigue syndrome. Initially, it was thought that discovering a particular pattern of antibodies to this virus was helpful in the diagnosis of chronic fatigue syndrome, but this no longer appears to be the case.


As in any blood test, standard precautions should be performed to prevent infection at the site where the blood is obtained, and to prevent excess bleeding. Normally, the site is cleaned with an antiseptic liquid prior to the blood being obtained; a sterile non-reusable needle and syringe are used; and, once the needle is removed, pressure is placed at the site until bleeding has stopped.


These tests are more often performed in a consulting laboratory than at a physician's office or in a hospital laboratory. Like most antibody tests, they are performed on serum, the liquid part of the blood obtained after the whole blood is allowed to clot in a tube. Antibodies can be detected against several components of the Epstein-Barr virus (EBV). These components are the EBV early antigen (EA), the viral capsid antigen (VCA), and the nuclear antigen (EBNA). These several antigens are different proteins that are produced in the process (stages) of the virus' growth.

At the time of infection with Epstein-Barr virus, antibodies to EA are found and usually last for four to six months only. This antibody, however, persists substantially longer in about 10% of persons who have had EBV infection in the more remote past. The absence of antibody to EA when other EBV antibodies are present strongly suggests that first time infection with EBV occurred in the past.

Antibody to VCA is found both early and late in EBV infection. At the time of infection, antibody of both the IgM and IgG types are detectable. After four to six months, usually, only the IgG antibody against VCA can be found.

Unlike antibodies to EA and VCA, antibody to EBNA does not usually develop until recovery from first time infection of this virus. Therefore, finding detectable amounts of antibody to EBNA during an illness which might be caused by EBV makes the causal relationship very unlikely.


The skin area from which the blood sample will be obtained is wiped with an antiseptic such as alcohol or iodine.


The aftercare is similar to that for any blood test. Usually, pressure is applied to the area for several moments until bleeding stops. If the results are difficult to interpret, it may be necessary to re-test later, after waiting one to three weeks. The change in the amounts of antibody detected between the two tests can be particularly useful, at times, in helping to make a diagnosis.


There are no risks over and above those of having blood drawn for any other purpose. These tests are more expensive than many other blood tests but are usually covered by medical insurance.

Normal results

The pattern of the three antibodies can be used to determine whether the person has not had infection with EBV to this point (is susceptible to infection); is currently, or recently, infected with EBV for the first time; or has had first time infection with EBV sometime in the past (more than six months ago).

If one defines "normal" results as either not having EBV in the past, and call that category one; or having had it in the past, and call that category two. Most young children below the age of five will fall into category one, while most adults over the age of 20 years will fall into category two.

The results for susceptibility are:

  • antibody to EA = negative
  • antibody to VCA (either IgM or IgG) = negative
  • antibody to EBNA = negative

The results for past infection are:

  • antibody to EA = negative (90% of time)
  • antibody to VCA IgM = negative
  • Antibody to VCA IgG = positive
  • Antibody to EBNA = Positive.

It is important to realize that the Epstein-Barr virus, like all the human herpes viruses, does not totally leave the body after the patient recovers from illness. With EBV, the virus will intermittently recur in the saliva of people without any symptoms. Such people will have a test pattern of previous infection. It is this group of people who can transmit EBV to others without themselves being ill.

Abnormal results

The results for current or recent infection are:

  • antibody to EA = positive
  • antibody to VCA IgM = positive
  • antibody to VCA IgG = positive
  • antibody to EBNA = negative.

Without the pattern of the three antibodies, it can be difficult to be accurate in interpretation. The presence of antibody to VCA IgM is the best single test for current or recent first time infection.



Henle, G., W. Henle, and C. A. Horowitz. "Epstein-Barr Virus Specific Diagnosis: Tests in Infectious Mononucleosis." Human Pathology 5 (1997): 551-558.